Iopamidol Injection
IopamidolInjection is the second-generation non-ionic iodinated Contrast Media launched in the global market. In 2015, Beilu firstly launched and listed iopamiro injectionin the Chinese market. If you want to know iopamidol cost, please contact us.
Product name: Iopamidol Injectionnon
Generic name: Iopamidol Injection
Type: Injectable Contrast Media for CT/X-ray
Ingredients: iopamidol 300, iopamidol 370
Specification:
(1) 50ml: 15 gl
(2) 100ml: 30 gl
(3) 50ml: 18.5 gl
(4) 100ml: 37 gl
Administration: Intravascular injection
Adverse reactions: The application of organic iodine compounds can cause adverse reactions, as well as allergic or drug-induced shock. See the details from the package insert
Shelf life: 36 months
Advantages of Iopamidol Injection
High enhancement value, which increased the contrast between the lesion and solid organs, improved the lesion detection.
Low viscosity
Low osmotic pressure
Low injection speed, which reduces vascular pressure and prevents contrast media extravasation (patient with poor tolerance, such as children, elderly, diabetes or tumor patients, are more suitable for high-concentration contrast media)
The low total dosage of Contrast media
Low radiation dose
Indications of Iopamidol Injection
Neuroradiology: Spinal nerve root angiography, Cisternography and ventriculography.
Angiography: Cerebral arteriography, Coronary angiography, Thoracic aorta and abdominal aorta angiography, Angiocardiography, Selectivevisceral arteriography, Peripheral arteriography and venography, Digital subtraction angiography of cerebral arteries, peripheral arteries and abdominal arteries.
Urinary system angiography: Venous urography, Enhanced scan in CT examination, Arthrography, Fistula angiography, Digital subtraction angiography.
Precautions please refer to the package insert.
Founded in 1992, Beilu Pharmaceuticalis mainly engaged in the research & development, production and sales of pharmaceutical products. It is high-tech innovation company with core competence in the Contrast Media domestic. Beilu provides complete gadolinium contrast mediaproducts suitable for X-Ray and Magnetic Resonance Imaging (MRI), and it is the leading manufacturer in the Contrast Media field in China.
在线联系供应商
Other supplier products
 |
Ferric Ammonium Citrate Effervescent Granules | Ferric Ammonium Citrate Effervescent Granules was launched in 2004. It is an oral magnetic resonance contrast agent/media approved by NMPA in the m... |
 |
Iodixanol Injection | Iodixanol Injection is a CT/X-ray Contrast Media that is isotonic with plasma. It has excellent cardiac safety and renal safety, which is most comf... |
 |
Gadopentetate Dimeglumine Injection/API | Since Gadopentetate Dimeglumine Injection was launched in 1992 by Beilu Pharma in China, it was highly recommended and accepted by the radiologist,... |
 |
Gadopentetate Dimeglumine Injection/API | Since Gadopentetate Dimeglumine Injectionwas launched in 1992 by Beilu Pharma in China, it was highly recommended and accepted by the radiologist, ... |
 |
Iopamidol Injection | Iopamidol Injectionis the second-generation non-ionic iodinated Contrast Media launched in the global market. In 2015, Beilufirstly launched and li... |
Same products
 |
Calcobutrol | 卖方: 北京北陆药业股份有限公司 | Calcobutrol CAS No.: Molecular formula: C18H32CaN4O9 Molecular weight: 488.5461 Qual... |
 |
Repaglinide Tablets | 卖方: 北京北陆药业股份有限公司 | Repaglinide tabletsare non-sulfonylurea insulin secretion agents and are used to treat patients w... |
 |
MRI Contrast Media | 卖方: 北京北陆药业股份有限公司 | agnetic resonance imaging Contrast Media (MRI Contrast Media), also called Magnetic resonance ima... |
|
|
Iopamidol Injection | 卖方: 北京北陆药业股份有限公司 | IopamidolInjection is the second-generation non-ionic iodinated Contrast Media launched in the gl... |
 |
Iohexol Injection | 卖方: 北京北陆药业股份有限公司 | Iohexol Injection is a non-ionic Contrast Media. Compared with a traditional ionic Contrast Media... |
